Insight on Therapy Area

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

Click here to sort results by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

Stakeholder Opinions: Vaccine Antigen Delivery Technologies - Molecular systems to open new markets

Overview of vaccine antigen delivery technologies with detailed profiles and critical assessment of key approaches. Discussion of opportunities and challenges for the sector and outlook for the next decade.

Published By Datamonitor
19 May 2009 $3800
Buy
Report
Report

Forecast Insight: Fibromyalgia - Regulatory caution threatens EU market expansion

Provides analysis of key events and their impact on the fibromyalgia market over the last year (July 2008June 2009). Includes indication- and country-specific 10-year forecasts of key marketed, generic, and pipeline products to 2018.

Published By Datamonitor
03 Jun 2009 $15200
Buy
Report
Report

Forecast Insight: Attention-Deficit Hyperactivity Disorder - Shire to stay on top despite drug safety fears and generic competition

Provides analysis of key events and their impact on the ADHD market since 2008. Includes an event-based and country-specific 10 year forecast of key marketed, generic, and pipeline products to 2018 in the seven major markets.

Published By Datamonitor
03 Jul 2009 $15200
Buy
Report
Report

Stakeholder Opinions: Skin and Soft Tissue Infections - The end of the reign of vancomycin

This report gives a comprehensive overview of trends in epidemiology, diagnosis, treatment and referral patterns for skin and soft tissue infections (SSTIs). It discusses the challenges, opportunities and future developments for the SSTI drug market.

Published By Datamonitor
16 Jul 2009 $3800
Buy
Report
Report

Commercial Insight: Hormonal Contraceptives - Look beyond oral contraception for a competitive edge

Full analysis of the current and future hormonal contraceptives drug market, with country-specific forecasts to 2018 of marketed, generic, and key pipeline drugs in the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK).

Published By Datamonitor
02 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Antidepressants - Novel mechanism offers hope in depressed market

Analysis of the current and future antidepressant drug class market. Includes sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
08 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Anticonvulsants - Non-epilepsy label expansions provide blockbuster potential

Analysis of the future potential of anticonvulsants market. Includes sales forecasts over 2009-2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain, and the UK) of key marketed brands, generics, and pipeline agents.

Published By Datamonitor
08 Oct 2009 $15200
Buy
Report
Report

Commercial Insight: Antipsychotics - Revenues of depots and new agents will partially offset generic erosion

Analysis of the current and future antipsychotic market. Includes country-specific sales forecasts to 2018 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products.

Published By Datamonitor
28 Oct 2009 $15200
Buy
Report
Report

Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan

This report discusses four key Asian vaccines markets, India, China, South Korea and Taiwan. It analyzes the commercial and regulatory environment, guidelines, domestic and multinational competition as well as current and future indications.

Published By Datamonitor
02 Nov 2009 $3800
Buy
Report
Report

Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development

Comprehensive analysis of the gene therapy clinical pipeline across all geographic and therapeutic markets, with key opinion leader insights. Identification of drivers and inhibitors to the commercial success of gene therapy.

Published By Datamonitor
10 Dec 2009 $3800
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

No help is available.